Congenital Myasthenic Syndrome
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Congenital Myasthenic Syndrome

What is the definition of Congenital Myasthenic Syndrome?

Congenital myasthenic syndromes are a group of conditions that are characterized by weak muscles that tire easily (myasthenia). In people with these conditions, myasthenia typically begins shortly after birth or during early childhood. The most commonly affected muscles are the muscles in the head and neck (bulbar muscles) that control chewing and swallowing, speech, and facial expressions; the muscles that move the eyes and eyelids; and the muscles in the arms and legs. However, any of the muscles used for movement (skeletal muscles) can be affected.

What are the causes of Congenital Myasthenic Syndrome?

Variants (also called mutations) in more than 35 genes can cause congenital myasthenic syndromes. Variants in the CHRNE gene are responsible for about half of all cases. Variants in the COLQ and DOK7 genes are responsible for 20 to 30 percent of all cases. Variants in other genes are each responsible for a small percentage of cases.

How prevalent is Congenital Myasthenic Syndrome?

The prevalence of congenital myasthenic syndromes is estimated to be 2 in 1 million individuals worldwide. In people under 18 years of age, the prevalence is estimated to be 10 in 1 million individuals.

Is Congenital Myasthenic Syndrome an inherited disorder?

Congenital myasthenia syndromes are usually inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a variant to cause the disorders. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the conditions.

Who are the top Congenital Myasthenic Syndrome Local Doctors?
Elite in Congenital Myasthenic Syndrome
Elite in Congenital Myasthenic Syndrome

UC Davis Neurosciences Clinic

3160 Folsom Blvd Ste 2100, 
Sacramento, CA 
Languages Spoken:
English

Ricardo Maselli is a Neurologist practicing medicine in Sacramento, California. Dr. Maselli is rated as an Elite provider by MediFind in the treatment of Congenital Myasthenic Syndrome. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Congenital Myasthenic Syndrome, Lambert-Eaton Syndrome, Amyotonia Congenita, and ADULT Syndrome.

Elite in Congenital Myasthenic Syndrome
Elite in Congenital Myasthenic Syndrome
Central Parkway, 
Newcastle Upon Tyne, ENG, GB 

Hanns Lochmuller practices practicing medicine in Newcastle Upon Tyne, United Kingdom. Mr. Lochmuller is rated as an Elite expert by MediFind in the treatment of Congenital Myasthenic Syndrome. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Congenital Myasthenic Syndrome, Myotonic Dystrophy, Myotonic Dystrophy Type 2, and Paramyotonia Congenita.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Congenital Myasthenic Syndrome
Pediatric Neurology
Elite in Congenital Myasthenic Syndrome
Pediatric Neurology

MN - Neuro Pediatric

200 1st St SW, 
Rochester, MN 
Languages Spoken:
English

Duygu Selcen is a Pediatric Neurologist practicing medicine in Rochester, Minnesota. Dr. Selcen is rated as an Elite provider by MediFind in the treatment of Congenital Myasthenic Syndrome. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Congenital Myasthenic Syndrome, Congenital Fiber-Type Disproportion, X-Linked Myotubular Myopathy, and Tubular Aggregate Myopathy.

What are the latest Congenital Myasthenic Syndrome Clinical Trials?
Multicenter, Multinational, Natural History Study in Participants With Congenital Myasthenic Syndromes Due to Mutations in DOK7, MUSK, AGRN, or LRP4

Summary: Participants will attend up to 4 study visits to collect clinical assessments. The assessments will evaluate participants' symptoms and quality of life to understand disease activity in patients with CMS due to mutations in DOK7, MUSK, AGRN, or LRP4. More information can be found here: https://clinicaltrials.argenx.com/cms

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Single Center Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes

Background: Congenital myasthenic syndromes (CMSs) are a group of inherited disorders that affect how the nerves communicate with muscles. These can cause many problems that affect how people can move and use their bodies.

Who are the sources who wrote this article ?

Published Date: February 13, 2026
Published By: National Institutes of Health